As the field continues to advance, integrating genetic information into treatment strategies will be essential for improving outcomes and developing targeted therapies for Alzheimer’s ... May 08
Latest pharma news update... Sep 16
Lecanemab is indicated for the treatment of Alzheimer’s Disease... Jun 26
The companies are planning to move into the registrational stage of development for this asset as early as next year.... Jun 21
... Jun 18
Gilead and Galapagos will continue to investigate the potential for filgotinib to support patients living with Inflammatory Bowel Disease... Dec 16
... Dec 16
Today, Biogen and Eisai, Co., Ltd. announced that Biogen has submitted a Japanese New Drug Application (J-NDA) to the Ministry of Health, Labor and ... Dec 10
... Dec 09
... Dec 01
The collaboration will use Wren's network kinetics drug discovery platform, alongside Eisai's extensive experience in drug discovery for neurodegenerative disorders... Nov 30
The approval was based on the results of Phase III and Phase II clinical studies conducted globally to evaluate Fycompa as an adjunctive therapy in ... Nov 16
LENVIMA plus everolimus were evaluated versus sunitinib for the first-line treatment of patients with advanced renal cell carcinoma... Nov 10
Public Citizen's Health Research Group said that the FDA should not approve aducanumab for treatment of Alzheimer's disease due to lack of evidence ... Nov 07
This collaborative research, aims to elucidate the mechanism of COVID-19 aggravation based on SARS-CoV-2 infection and to create drugs that prevent the ... Oct 08
The FDA now has up to 60 days to decide whether to accept the application for review... Jul 09
For Cutaneous T-Cell Lymphoma and Peripheral T-Cell Lymphoma... Mar 30
A new chapter of the widely appreciated India Pharma Week by Informa Markets in India concurrently began at the India Expo Centre, Greater Noida... Nov 27
-Advertisements-
.jpeg)
Friday, November 22, 2024
..jpg)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)